Paul Andrew Gendron net worth and biography

Paul Gendron Biography and Net Worth

Director of InfuSystem

Paul A. Gendron has been a member of the Company's Board of Directors since May 15, 2019. Mr. Gendron also served as a financial consultant to the Company from January 2019 until his election to the Board. Previously, he was a client service partner with PriceWaterhouseCoopers LLP where he held various leadership roles, including North Texas Market Assurance Leader, U.S. Assurance Talent Transformation Leader, and Southwest Region Technology Practice Risk Management Leader. In his Market Assurance Leader role, Mr. Gendron lead the Assurance practice in the Dallas, Fort Worth, Austin and Little Rock offices, providing services in internal and external audit, risk and information technology assurance, and accounting and capital markets advisory. Mr. Gendron is a CPA and holds a Bachelor of Business Administration degree in accounting from the University of Texas at Austin. He has served on non-profit boards during his career as well as the Accounting Advisory Council at the University of Texas at Austin.

Mr. Gendron brings over 30 years of public accounting experience at PriceWaterhouseCoopers LLP, including 22 years as audit partner, where he served global public and private multibillion-dollar corporations. His areas of strength include board governance, audit project management, risk management, executive management, public offerings, and mergers and acquisitions.

What is Paul Andrew Gendron's net worth?: The estimated net worth of Paul Andrew Gendron is at least $623 thousand as of May 8th, 2026. Mr. Gendron owns 70,000 shares of InfuSystem stock worth more than $623,000 as of July 23rd. This net worth estimate does not reflect any other assets that Mr. Gendron may own. Learn More about Paul Andrew Gendron's net worth.
How do I contact Paul Andrew Gendron?: The corporate mailing address for Mr. Gendron and other InfuSystem executives is 3851 West Hamlin Road, Rochester Hills, MI 48309, United States. InfuSystem can also be reached via phone at (248) 291-1210. Learn More on Paul Andrew Gendron's contact information.
Has Paul Andrew Gendron been buying or selling shares of InfuSystem?: Paul Andrew Gendron has not been actively trading shares of InfuSystem over the course of the past ninety days. Most recently, on Friday, May 8th, Paul Andrew Gendron bought 5,000 shares of InfuSystem stock. The stock was acquired at an average cost of $8.88 per share, with a total value of $44,400.00. Following the completion of the transaction, the director now directly owns 70,000 shares of the company's stock, valued at $621,600. Learn More on Paul Andrew Gendron's trading history.
Who are InfuSystem's active insiders?: InfuSystem's insider roster includes Kenneth Eichenbaum (Director), Paul Gendron (Director), Carrie Lachance (President and Chief Executive Officer), and Barry Steele (Executive Vice President and Chief Financial Officer). Learn More on InfuSystem's active insiders.
Are insiders buying or selling shares of InfuSystem?: During the last year, InfuSystem insiders bought shares 5 times. They purchased a total of 17,064 shares worth more than $150,396.24. During the last year, insiders at the sold shares 1 times. They sold a total of 5,752 shares worth more than $55,621.84. The most recent insider tranaction occured on May, 11th when CEO Carrie Lachance bought 1,000 shares worth more than $8,460.00. Insiders at InfuSystem own 10.8% of the company. Learn More about insider trades at InfuSystem.
Information on this page was last updated on 5/11/2026.

Paul Andrew Gendron Insider Trading History at InfuSystem

Transaction Date	Buy/Sell	Number of Shares	Average Share Price	Total Transaction	Shares Held After Transaction
5/8/2026	Buy	5,000	$8.88	$44,400.00	70,000
5/20/2024	Buy	5,000	$6.54	$32,700.00	65,000
2/11/2022	Buy	10,000	$10.67	$106,700.00
3/25/2021	Buy	3,000	$20.34	$61,020.00	25,000
3/23/2020	Buy	10,000	$5.77	$57,700.00	22,000

Paul Andrew Gendron Buying and Selling Activity at InfuSystem

InfuSystem Company Overview

InfuSystem Holdings, Inc., through its subsidiaries, provides infusion pumps, and related products and services in the United States and Canada. The company operates in two segments, Patient Services and Device Solutions. It supplies electronic ambulatory infusion pumps and associated disposable supply kits to oncology, infusion, and hospital outpatient chemotherapy clinics for the treatment of various cancers, including colorectal cancer, pain management, and other disease states. The company also sells, rents, and leases new and pre-owned pole-mounted and ambulatory infusion pumps, and other durable medical equipment; sells treatment-related consumables; and provides biomedical recertification, maintenance, and repair services for oncology practices, as well as other healthcare site settings comprising hospitals, home care and home infusion providers, skilled nursing and acute care facilities, pain centers, and others. In addition, it offers local and field-based customer support, as well as operates pump service and repair centers. The company was incorporated in 2005 and is headquartered in Rochester Hills, Michigan.

Today's Range

Now: $8.91

$8.88

$8.92

50 Day Range

MA: $9.31

$8.61

$10.16

2 Week Range

Now: $8.91

$5.43

$11.04

Volume

5,225 shs

Average Volume

168,649 shs

Market Capitalization

$179.72 million

P/E Ratio

148.44

Dividend Yield

N/A

Beta

1.4